Urticaria- bane or boon to treat with omalizumab? A case series

Authors

  • Sowmya Arudi Nagarajan
  • Harsha NS
  • Nagashree V Sharma

DOI:

https://doi.org/10.32677/IJCR.2019.v05.i04.001

Keywords:

Antihistamines, Anti-IgE, Monoclonal antibody, Omalizumab, Urticaria.

Abstract

Chronic spontaneous urticaria (CSU) is a condition characterised by the presence of hives with/without angioedema that affects individuals on more days than not for 6 weeks or more. This can be a very debilitating condition affecting the quality of life. Here, we report 3 cases of severe prolonged chronic spontaneous urticaria in 7-year-old, 20-year-old and 25-year-old individuals that went into rapid remission following the treatment with Omalizumab, anti-IgE monoclonal antibody.

Downloads

Download data is not yet available.

Downloads

Published

2019-08-26

Issue

Section

Case Series

How to Cite

Urticaria- bane or boon to treat with omalizumab? A case series. (2019). Indian Journal of Case Reports, 5(4), 305-307. https://doi.org/10.32677/IJCR.2019.v05.i04.001

Most read articles by the same author(s)

<< < 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 > >>